White blood cell count adds prognostic information to the thrombolysis in myocardial infarction risk index in patients following primary percutaneous coronary intervention (ANIN Myocardial Infarction Registry)

International Journal of Cardiology

Volumn 116, Issue 3, 2007, Pages 376-382

  Kruk, Mariusz ^a   Karcz, Maciej ^a   Przyłuski, Jakub ^a   Bekta, Paweł ^a   Kepka, Cezary ^a   Kalińczuk, Łukasz ^a   Pregowski, Jerzy ^a   Kaczmarska, Edyta ^a   Demkow, Marcin ^a   Chmielak, Zbigniew ^a   Witkowski, Adam ^a   Ruzyłło, Witold ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

Inflammation; Primary angioplasty; ST elevation myocardial infarction; TIMI risk index; WBC count

Indexed keywords

ADULT; ARTICLE; BLOOD CLOT LYSIS; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; INFLAMMATION; KAPLAN MEIER METHOD; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIVARIATE ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; REGISTER; RISK ASSESSMENT; SMOKING; ST SEGMENT ELEVATION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; HEALTH STATUS INDICATORS; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REGISTRIES; RISK ASSESSMENT; THROMBOLYTIC THERAPY;

EID: 33847106451     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.03.061     Document Type: Article

References (25)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
2. Hochman J.S. Cardiogenic shock complicating acute myocardial infarction circulation 107 (2003) 2998-3002
3. Schlant R.C., Forman S., Stamler J., and Canner P.L. The natural history of coronary heart disease: prognostic factors after recovery from myocardial infarction in 2789 men. The 5-year findings of the Coronary Drug Project. Circulation 66 (1982) 401-414
4. Barron H.V., Cannon C.P., Murphy S.A., Braunwald E., and Gibson C.M. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction. Circulation 102 (2000) 2329-2334
5. Furman M.I., Gore J.M., Anderson F.A., et al., GRACE Investigators. Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 147 (2004) 42-48
6. Menon V., Lessard D., Yarzebski J., Furman M.I., Gore J.M., and Goldberg R.J. Leukocytosis and adverse hospital outcomes after acute myocardial infarction. Am J Cardiol 92 (2003) 368-372
7. Kojima S., Sakamoto T., Ishihara M., et al., Japanese Acute Coronary Syndrome Study Investigators. The white blood cell count is an independent predictor of no-reflow and mortality following acute myocardial infarction in the coronary interventional era. Ann Med 36 2 (2004) 153-160
8. Cannon C.P., McCabe C.H., Wilcox R.G., Bentley J.H., Braunwald E., and for the OPUS-TIMI 16 Investigators. Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris. Am J Cardiol 87 (2001) 636-639
9. Patel M.R., Mahaffey K.W., Armstrong P.W., et al., CARDINAL Investigators. Prognostic usefulness of white blood cell count and temperature in acute myocardial infarction (from the CARDINAL Trial). Am J Cardiol 95 (2005) 614-618
10. Pellizzon G.G., Dixon S.R., Stone G.W., et al., Stent PAMI Investigators. Relation of admission white blood cell count to long-term outcomes after Primary coronary Angioplasty for acute Myocardial Infarction (The Stent PAMI Trial). Am J Cardiol 91 (2003) 729-731
11. Bhatt D.L., Chew D.P., Lincoff A.M., et al., PURSUIT Investigators. Effect of revascularization on mortality associated with an elevated white blood cell count in acute coronary syndromes. Am J Cardiol 92 (2003) 136-140
12. Morrow D.A., Antman E.M., Giugliano R.P., et al. A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy. Lancet 358 (2001) 1571-1575
13. Wiviott S.D., Morrow D.A., Frederick P.D., et al. Performance of the Thrombolysis In Myocardial Infarction Risk Index in the National Registry of Myocardial Infarction-3 and - 4. J Am Coll Cardiol 44 (2004) 783-789
14. Arroyo-Espliguero R., Avanzas P., Cosin-Sales J., Aldama G., Pizzi C., and Kaski J.C. C-reactive protein elevation and disease activity in patients with coronary artery disease. Eur Heart J 25 5 (Mar 2004) 401-408
15. Wagner D.D. New links between inflammation and thrombosis. Arterioscler Thromb Vasc Biol 25 (2005) 1321-1324
16. Burr M.L., Holliday R.M., Fehily A.M., and Whitehead P.J. Haematological prognostic indices after myocardial infarction: evidence from the Diet and Reinfarction Trial (DART). Eur Heart J 13 (1992) 166-170
17. Lowe G.D., Machado S.G., Krol W.F., Barton B.A., and Forbes C.D. White blood cell count and haematocrit as predictors of coronary recurrence after myocardial infarction. Thromb Haemost 54 (1985) 700-703
18. Suryapranata H., De Luca G., van 't Hof A.W.J., et al. Is routine stenting for acute myocardial infarction superior to balloon angioplasty? A randomised comparison in a large cohort of unselected patients. Heart 91 (2005) 641-645
19. Fernandez-Aviles F., Alonso J.J., Castro-Beiras A., et al., GRACIA (Grupo de Analisis de la Cardiopatia Isquemica Aguda). Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial. Lancet 364 (2004) 1045-1053
20. GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function and survival after acute myocardial infarction. N Engl J Med 329 (1993) 1615-1622
21. Grines C.L., Browne K.F., Marco J., et al., for the Primary Angioplasty in Myocardial Infraction Study Group. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. Primary Angioplasty in Myocardial Infarction Study Group (PAMI). N Engl J Med 328 (1993) 673-679
22. Yan A.T., Jong P., Yan R.T., et al. Clinical trial- derived risk model may not generalize to real-world patients with acute coronary syndrome. Am Heart J 148 (2004) 1020-1027
23. De Luca G., Suryapranata H., van't Hof A.W., et al. Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty. Circulation 109 (2004) 2737-2743
24. Gibson C.M., Pinto D.S., Murphy S.A., et al., TIMI Study Group. Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. J Am Coll Cardiol 42 (2003) 1535-1543
25. Hanania G., Cambou J.P., Gueret P., et al., USIC 2000 Investigators. Management and in-hospital outcome of patients with acute myocardial infarction admitted to intensive care units at the turn of the century: results from the French nationwide USIC 2000 registry. Heart 90 12 (Dec 2004) 1404-1410